BIOA — BioAge Labs
Median target
$21
calls from the last 12 months
Implied return
+159.6%
median target vs. price
Coverage
6 analysts · 6 calls
updated in the last 12 months
Consensus
3/3/0+3 net
Buy / Hold / Sell
Which analysts are behind BIOA's consensus?
See every current rating, price target and the analysts' track records for BioAge Labs — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 6 analysts with calls on BIOA updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
BIOA elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2016-06-09 | Congress | Suzan K. DelBeneWA-WA01 | Sale | – | $1K–$15K |
| 2014-10-10 | Congress | Suzan K. DelBeneWA-WA01 | Purchase | – | $1K–$15K |
| 2014-10-09 | Congress | Suzan K. DelBeneWA-WA01 | Purchase | – | $1K–$15K |
| 2014-07-24 | Congress | Suzan K. DelBeneWA-WA01 | Purchase | – | $15K–$50K |
More: congressional trades on BIOA · insider activity · executive branch · trending